도침 서브시전, Q-switched Nd: YAG 레이저, PDRN 약침을 이용한 3단계 통합 치료 프로토콜에 의한 수술 후 비후성 흉터 치험 1례
Three-Step Integrative Treatment of a Post-Surgical Hypertrophic Scar Using Subcision, Q-switched Nd:YAG Laser, and PDRN Pharmacopuncture: A Case Report
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Abstract Objectives : This case report presents a three-step integrative treatment protocol for hypertrophic scarring involving subcision (dochim), Q-switched Nd:YAG laser therapy, and polydeoxyribonucleotide (PDRN) pharmacopuncture. Methods : A 26-year-old male with a post-surgical facial hypertrophic scar received sequential treatment: subcision to release fibrotic adhesions, 1064-㎚ Nd:YAG laser therapy (spot size 7㎜; fluence 2.07–2.59J/㎠; frequency 5–7㎐) until delayed petechiae appeared, and 2 mL of PDRN pharmacopuncture to promote VEGF expression and fibroblast activation. Outcomes were assessed using SBSES, QIS, and a Likert scale for patient satisfaction. Results : After two months, SBSES improved from 3 to 1, QIS from 3 to 4, and patient satisfaction from 4 to 5. No adverse events were observed. Conclusions : This case suggests that combining subcision, Nd:YAG laser, and PDRN pharmacopuncture may offer an effective integrative strategy for hypertrophic scar management. Further studies are needed to validate these findings
Abstract
Abstract Objectives : This case report presents a three-step integrative treatment protocol for hypertrophic scarring involving subcision (dochim), Q-switched Nd:YAG laser therapy, and polydeoxyribonucleotide (PDRN) pharmacopuncture. Methods : A 26-year-old male with a post-surgical facial hypertrophic scar received sequential treatment: subcision to release fibrotic adhesions, 1064-㎚ Nd:YAG laser therapy (spot size 7㎜; fluence 2.07–2.59J/㎠; frequency 5–7㎐) until delayed petechiae appeared, and 2 mL of PDRN pharmacopuncture to promote VEGF expression and fibroblast activation. Outcomes were assessed using SBSES, QIS, and a Likert scale for patient satisfaction. Results : After two months, SBSES improved from 3 to 1, QIS from 3 to 4, and patient satisfaction from 4 to 5. No adverse events were observed. Conclusions : This case suggests that combining subcision, Nd:YAG laser, and PDRN pharmacopuncture may offer an effective integrative strategy for hypertrophic scar management. Further studies are needed to validate these findings